Bourcier R, Volpi S, Guyomarch B, Daumas-Duport B, Lintia-Gaultier A, Papagiannaki C, Serfaty J M, Desal H
From the Departments of Diagnostic and Interventional Neuroradiology (R.B., S.V., B.D.-D., A.L.-G., H.D.)
From the Departments of Diagnostic and Interventional Neuroradiology (R.B., S.V., B.D.-D., A.L.-G., H.D.).
AJNR Am J Neuroradiol. 2015 Dec;36(12):2346-53. doi: 10.3174/ajnr.A4483. Epub 2015 Aug 27.
The susceptibility vessel sign on MR imaging has been reported to indicate acute occlusion from erythrocyte-rich thrombus. The purpose of this study was to evaluate the influence of the susceptibility vessel sign seen on MR imaging before treatment on the clinical outcome after mechanical thrombectomy for anterior circulation acute stroke.
We retrospectively included 73 consecutive patients who were treated for anterior circulation acute stroke by mechanical thrombectomy from December 2009 to September 2013. Each patient underwent MR imaging before mechanical thrombectomy. The presence (susceptibility vessel sign+) or absence of the susceptibility vessel sign (susceptibility vessel sign-) was recorded. Mechanical thrombectomy was performed either alone or in association with IV tPA according to the site and time after occlusion. Good functional outcome was defined by an mRS ≤ 2 at 3 months in susceptibility vessel sign+ and susceptibility vessel sign- groups. Patient clinical characteristics, initial NIHSS score and ASPECTS, site of occlusion, time between onset to groin puncture, TICI after mechanical thrombectomy, NIHSS score at day 1, and spontaneous hyperattenuation on CT at day 1 were also analyzed.
Fifty-three patients with susceptibility vessel sign+ and 20 with susceptibility vessel sign- were included in our study. mRS ≤ 2 at 3 months occurred in 65% patients in the susceptibility vessel sign+ group and 26% in the susceptibility vessel sign- group (P = .004). On multivariate analysis, the susceptibility vessel sign was the only parameter before treatment that could predict mRS ≤ 2 at 3 months (OR, 8.7; 95% CI, 1.1-69.4; P = .04).
Our study strongly suggests that the susceptibility vessel sign on MR imaging before treatment is predictive of favorable clinical outcome for patients presenting with anterior circulation acute stroke and treated with mechanical thrombectomy.
据报道,磁共振成像(MR)上的血管敏感征提示富含红细胞血栓导致的急性闭塞。本研究旨在评估治疗前MR成像所见血管敏感征对前循环急性卒中机械取栓术后临床结局的影响。
我们回顾性纳入了2009年12月至2013年9月期间接受前循环急性卒中机械取栓治疗的73例连续患者。每位患者在机械取栓前均接受了MR成像检查。记录血管敏感征阳性(血管敏感征+)或阴性(血管敏感征-)的情况。根据闭塞部位和时间,单独或联合静脉注射组织型纤溶酶原激活剂(IV tPA)进行机械取栓。血管敏感征+组和血管敏感征-组在3个月时改良Rankin量表(mRS)评分≤2定义为良好功能结局。还分析了患者的临床特征、初始美国国立卫生研究院卒中量表(NIHSS)评分和脑缺血半暗带早期CT评分(ASPECTS)、闭塞部位、发病至股动脉穿刺时间、机械取栓后脑梗死溶栓分级(TICI)、第1天的NIHSS评分以及第1天CT上的自发性高密度影。
本研究纳入了53例血管敏感征+患者和20例血管敏感征-患者。血管敏感征+组65%的患者在3个月时mRS评分≤2,血管敏感征-组为26%(P = 0.004)。多因素分析显示,血管敏感征是治疗前唯一能预测3个月时mRS评分≤2的参数(比值比,8.7;95%可信区间,1.1 - 69.4;P = 0.04)。
我们的研究强烈表明,治疗前MR成像上的血管敏感征可预测前循环急性卒中并接受机械取栓治疗患者的良好临床结局。